CVE-2025-7674: Roche Diagnostics Navify Monitoring

High severity, CVSS 7.1. EPSS: 0.3% chance of exploitation in the next 30 days.

Improper Input Validation vulnerability in Roche Diagnostics navify Monitoring allows an attacker to manipulate input data, which may lead to a denial of service (DoS) due to negatively impacting the server's performance. This vulnerability has no impact on data confidentiality or integrity. This issue affects navify Monitoring before 1.08.00.

Affected products

Published 2025-08-05. Last modified 2026-06-17.